Clinical Trial Update: Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial investigating molecular genetics-guided maintenance therapy after allogeneic hematopoietic stem cell transplantation for acute my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Ruijin Hospital | Conditions: AML, MDS | Phase 2, Phase 3 | Status: RECRUITING